Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Brain Neoplasms × Carboplatin × Clear all

Phase

Phase 2 20 Phase 1/2 8 Phase 1 8 Phase 3 4 Phase NA 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Lymphoma, B-Cell 1 Head and Neck Neoplasms 1 Glioma 1 Fallopian Tube Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6 Biopsy 3 Bevacizumab 3 posaconazole 2 fluciclovine F-18 2 Topotecan 2 Temozolomide 2 Specimen Handling 2 Radiosurgery 2 Pemetrexed 2 Nivolumab 2 Methotrexate 2 Ketoconazole 2 Fluorodeoxyglucose F18 2 ribociclib 1 relatlimab 1 mycophenolic adenine dinucleotide 1 montelukast 1 gancotamab 1 fluoromisonidazole 1 fluorodopa F 18 1 fludarabine phosphate 1 etoposide phosphate 1 eribulin 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 clevudine 1 ceritinib 1 brivaracetam 1 auricularum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02279992 2017-09-11

LevitraCarbo

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡